Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
British Journal of Cancer
|
July 30, 2014
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
C Y Cheah, K E Herbert, K O'Rourke, et al.
Hematological Oncology
|
April 16, 2019
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma
Zi Yun Ng, Mark Bishton, David Ritchie, et al.
Internal Medicine Journal
|
September 24, 2023
Chronic lymphocytic leukaemia Australasian consensus practice statement
Mary A Anderson, Rory Bennett, Xavier Badoux, et al.
NEJM Evidence
|
June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma
Angie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
Haematologica
|
October 15, 2020
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion
Constantine S Tam, Tadeusz Robak, Paolo Ghia, et al.
Blood Advances
|
September 8, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
Stephen Opat, Alessandra Tedeschi, Bei Hu, et al.
Ejhaem
|
August 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, et al.
The Lancet. Oncology
|
September 5, 2020
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
Othman Al-Sawaf, Can Zhang, Maneesh Tandon, et al.
Internal Medicine Journal
|
July 7, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update
Sean McKeague, Joanna Katarzyna Czerwinski, Xavier Badoux, et al.
Leukemia
|
April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
Jonathan Wong, Emily Gruber, Belinda Maher, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
British Journal of Cancer
|
July 30, 2014
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
C Y Cheah, K E Herbert, K O'Rourke, et al.
Hematological Oncology
|
April 16, 2019
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma
Zi Yun Ng, Mark Bishton, David Ritchie, et al.
Internal Medicine Journal
|
September 24, 2023
Chronic lymphocytic leukaemia Australasian consensus practice statement
Mary A Anderson, Rory Bennett, Xavier Badoux, et al.
NEJM Evidence
|
June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma
Angie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
Haematologica
|
October 15, 2020
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion
Constantine S Tam, Tadeusz Robak, Paolo Ghia, et al.
Blood Advances
|
September 8, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
Stephen Opat, Alessandra Tedeschi, Bei Hu, et al.
Ejhaem
|
August 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, et al.
The Lancet. Oncology
|
September 5, 2020
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
Othman Al-Sawaf, Can Zhang, Maneesh Tandon, et al.
Internal Medicine Journal
|
July 7, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update
Sean McKeague, Joanna Katarzyna Czerwinski, Xavier Badoux, et al.
Leukemia
|
April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
Jonathan Wong, Emily Gruber, Belinda Maher, et al.
Page
of 14